#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15676	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2500	771.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1624	1624	C	944	C,G,T	942,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26750	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3952	842.6	0	.	n	.	0	T695C	SNP	695	695	T	1196	1196	C	1003	C,T,A	999,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26750	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3952	842.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2472	2472	C	962	C,G	960,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26750	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3952	842.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2546	2546	A	886	A,T,C	884,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26750	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3952	842.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3098	3098	C	957	C,T,A	953,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	42088	blaTEM	861	861	100.0	blaTEM.l15.c4.ctg.1	2104	2493.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2184	folP	855	855	100.0	folP.l15.c4.ctg.1	2050	132.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1293	1295	AGC	225;226;223	A;G;C	225;226;223	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5244	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3922	166.5	0	.	p	.	0	G95A	NONSYN	283	285	GGC	813	815	GCC	196;198;198	G;C,G;C,T	196;197,1;197,1	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	5244	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3922	166.5	1	SNP	p	S91F	1	.	.	271	273	TTC	801	803	TTC	201;201;197	T,C;T;C,T	200,1;201;196,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1940	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1828	132.2	1	SNP	p	G45D	0	.	.	133	135	GGC	788	790	GGC	207;204;206	G,T;G;C	206,1;204;206	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1104	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1313	104.4	0	.	n	.	0	A197.	DEL	197	197	A	711	711	A	224	A	224	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5100	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3432	185.5	1	SNP	p	D86N	0	.	.	256	258	GAC	818	820	GAC	227;228;228	G,T,C;A,C;C	224,1,1;227,1;228	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5100	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3432	185.5	1	SNP	p	S88P	0	.	.	262	264	TCC	824	826	TCC	228;230;232	T;C,G;C	228;229,1;232	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4394	parE	1986	1986	99.85	parE.l15.c4.ctg.1	3368	162.7	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1733	1735	TGC	221;223;220	T,G;G;C	220,1;223;220	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4394	parE	1986	1986	99.85	parE.l15.c4.ctg.1	3368	162.7	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	2081	2083	TCC	240;237;238	T,C;C;C	239,1;237;238	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4394	parE	1986	1986	99.85	parE.l15.c4.ctg.1	3368	162.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1943	1945	GGC	227;228;223	G;G;C	226;227;223	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1460	1462	GCA	262;261;263	G,A,T;C;A,T	260,1,1;261;262,1	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1463	1465	ATC	266;266;267	A;T;C,G	266;266;266,1	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1475	1477	GTG	271;270;268	G;T;G,A,T	271;270;266,1,1	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1475	1477	GTG	271;270;268	G;T;G,A,T	271;270;266,1,1	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1979	1981	ACC	245;244;244	A;C,G;C	245;243,1;244	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2033	2035	GCG	229;228;227	G;C,A;G,T,C	229;225,2;224,1,1	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2033	2035	GCG	229;228;227	G;C,A;G,T,C	229;225,2;224,1,1	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2156	2158	GGC	267;267;270	G;G;C	267;267;270	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2165	2167	GGC	262;258;254	G;G,T;C	262;257,1;254	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	4202	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2906	180.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2183	2185	CCG	249;247;245	C,G;C;G	248,1;246;244	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5452	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3445	197.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1815	1817	CCG	237;237;239	C,G;C;G	236,1;237;239	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2274	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2255	125.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	630	632	GGC	130;128;128	G,A;G,C;C	129,1;127,1;128	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2274	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2255	125.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	812	812	C	189	C	189	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2065	184.3	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	876	878	AAG	253;252;252	A,T,C;A;G	251,1,1;252;252	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2065	184.3	0	.	p	.	0	R257G	NONSYN	769	771	AGG	1287	1289	GGG	238;240;236	G;G,T;G	238;239,1;236	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2065	184.3	0	.	p	.	0	R258K	NONSYN	772	774	AGG	1290	1292	AAG	239;241;239	A;A;G,A	239;240;238,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2065	184.3	1	SNP	p	D121N	0	.	.	361	363	GAC	879	881	GAC	247;247;246	G,T,C,A;A,T;C	244,1,1,1;246,1;246	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3064	porB1b	1047	1047	99.43	porB1b.l6.c4.ctg.1	2065	184.3	1	SNP	p	A121D	1	.	.	361	363	GAC	879	881	GAC	247;247;246	G,T,C,A;A,T;C	244,1,1,1;246,1;246	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	9940	rpoB	4179	4179	99.88	rpoB.l6.c4.ctg.1	5302	233.5	0	.	p	.	0	G248D	NONSYN	742	744	GGC	1274	1276	GAC	300;302;301	G;A;C,G	300;302;300,1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	9940	rpoB	4179	4179	99.88	rpoB.l6.c4.ctg.1	5302	233.5	0	.	p	.	0	E1175D	NONSYN	3523	3525	GAG	4055	4057	GAC	262;260;259	G;A;C	262;260;259	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	9940	rpoB	4179	4179	99.88	rpoB.l6.c4.ctg.1	5302	233.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2189	2191	AAT	257;257;257	A;A;T	257;257;257	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1508	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1413	132.5	1	SNP	p	V57M	1	.	.	169	171	ATG	712	714	ATG	278;276;277	A,C;T;G	277,1;276;277	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	10844	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2950	457.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
